PREVENTION OF CHOLELITHIASIS
- Authors: Tonkikh Y.1, Chukanov V.1, Vasyutin A.1, Bronnikov E.1
-
Affiliations:
- Research Institute of Medical Problems of the North
- Issue: Vol 27, No 10 (2016)
- Pages: 41-43
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116656
- ID: 116656
Cite item
Open Access
Access granted
Abstract
The paper gives evidence for the expediency and efficiency of preventing cholelithiasis, the important methods of which are to increase physical activity, to lose weight, and to modify a diet. It provides a rationale for using ursodeoxycholic acid in the risk group to prevent cholelithiasis.
Keywords
Full Text
About the authors
Yu. Tonkikh
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Candidate of Medical Sciences
V. Chukanov
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Professor
A. Vasyutin
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Candidate of Medical Sciences
E. Bronnikov
Research Institute of Medical Problems of the North
Email: gastro@impn.ru
Candidate of Biological Sciences
References
- European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones // J. Hepatol. - 2016; 65 (1): 146-81.
- Тонких Ю.Л., Бронникова Е.П., Цуканов В.В. Распространенность и факторы риска заболеваний желчевыводящих путей у коренных жителей Тывы // Здравоохранение Российской Федерации. - 2014; 58 (5): 42-5.
- Агеева Е.С., Штыгашева О.В., Цуканов В.В. и др. Иммунологические особенности течения гастродуоденальной патологии у жителей Хакасии // Иммунология. - 2009; 30 (3): 162-4.
- Цуканов В.В., Куперштейн Е.Ю., Тонких Ю.Л. и др. Ассоциация жирнокислотного состава сыворотки крови с липидным составом желчи у больных холелитиазом // Тер. арх. - 2008; 80 (2): 71-5.
- Цуканов В.В., Куперштейн Е.Ю., Тонких Ю.Л. и др. Спектр жирных кислот и липидов сыворотки крови у больных холелитиазом // Клин. медицина. - 2009; 87 (2): 42-4.
- Chen L., Qiao Q., Zhang S. et al. Metabolicsyndrome and gallstone disease // World J.Gastroenterol. - 2012; 18: 4215-20.
- Stender S., Nordestgaard B., Tybjaerg-Hansen A. Elevated body mass indexas a causal risk factor for symptomatic gallstone disease: a mendelianrandomization study // Hepatology. - 2013; 58: 2133-41.
- Kriska A., Brach J., Jarvis B. et al. Physical activity and gallbladder disease determined by ultrasonography // Med. Sci. Sports Exerc. - 2007; 39: 1927-32.
- Banim P., Luben R., Wareham N. et al. Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study // Eur. J. Gastroenterol. Hepatol. - 2010; 22: 983-8.
- Lukicheva E., Tonkikh J., Kasparov E. et al. Lipid composition of bile, motor functions of the gallbladder and prevalence of biliary diseases in native inhabitants and new comers of Evenkia // Дальневосточный медицинский журнал. - 2011; 4: 23-6.
- Буторин Н.Н., Бичурина Т.Б., Цуканов В.В. и др. Распространенность и клинические аспекты пищевода Барретта у населения Восточной Сибири // Тер. арх. - 2013; 85 (1): 62-5.
- Цуканов В.В., Третьякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 22 (4): 27-31.
- Mendez-Sanchez N., Zamora-Valdes D., Chavez-Tapia N. et al. Role of diet in cholesterol gallstone formation // Clin. Chim. Acta. - 2007; 376: 1-8.
- Johansson K., Sundstrom J., Marcus C. et al. Risk ofsymptomatic gallstones and cholecystectomy after a very-low-calorie dietor low-calorie diet in a commercial weight loss program: 1-year matchedcohort study // Int. J. Obes. -2014; 38: 279-84.
- Festi D., Villanova N., Colecchia A. Risk factors for gallstone formation during weight loss // Clin. Gastroenterol. Hepatol. - 2015; 13: 613. ВРАЧ io'2oi6
- Stokes C., Gluud L., Casper M. et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials // Clin. Gastroenterol. Hepatol. - 2014; 12: 1090-100.
- Sugerman H., Brewer W., Shiffman M. et al. A multicenter, placebocontrolled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss // Am. J. Surg. - 1995; 169: 91-6.
- Attanasio R., Mainolfi A., Grimaldi F. et al. Somatostatin analogs and gallstones: a retrospective survey on a largeseries of acromegalic patients // J. Endocrinol. Invest. - 2008; 31: 704-10.
- Venneman N., van Erpecum K. Gallstone disease: primary and secondaryprevention // Best Pract. Res. Clin. Gastroenterol. - 2006; 20: 1063-73.
- Marjoribanks J., Farquhar C., Roberts H. et al. Long term hormone therapy for perimenopausal and postmenopausal women // Cochrane Database Syst. Rev. - 2012; 7: CD004143.
Supplementary files
